2026 NPPES data Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician NPI 1013921709 M.D.
Verify on CMS →

Peter Knapp, M.D.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician in Carmel, Indiana.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 621 in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 317 beneficiaries · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician avg: 661
Generic prescribing
86%
generic claims · 14% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
CMS neutral threshold · no category scores published
Industry payments
$147.47
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

Peter Knapp, M.D. carries the neutral CMS MIPS final score of 75/100, assigned where no category was scored - and filed 1,045 Medicare Part D claims in 2024.

75/100
CMS neutral score · not measured
1K
Part D claims, 2024
86%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Peter Knapp, M.D.

Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1013921709), first enumerated 07/28/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 1,045 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    CMS assigned a neutral MIPS final score of 75/100 where no performance category was scored — not a measured quality rank.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Industry payment transparency

    $147.47 in reported industry payments (1 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.

    Source: CMS Open Payments

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1013921709 · Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

NPI-10 · ENUM-LEGACY · TAX-NARROW · MIPS-NEUTRAL · RX-MID · BOOK-THIN · PHOTO-ENUM

  • NPI-10 1013921709
  • ENUM-LEGACY 2006
  • TAX-NARROW 621
  • MIPS-NEUTRAL 75/100
  • RX-MID 1,045
  • BOOK-THIN 14 in Indiana
  • PHOTO-ENUM Judith McNicholas · 2006

Peter Knapp, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2024, across all CMS prescribers nationally

1,045 ≥ 75th percentile 75% of 1,416,883 prescribers are in lower value bands

0–200: 679,947 prescribers (48%). Below this entry. 200–400: 188,835 prescribers (13%). Below this entry. 400–600: 95,866 prescribers (7%). Below this entry. 600–800: 60,107 prescribers (4%). Below this entry. 800–1,000: 43,043 prescribers (3%). Below this entry. 1,000–1,200: 33,612 prescribers (2%). This entry sits in this band. 1,200–1,400: 27,889 prescribers (2%). Above this entry. 1,400–1,600: 23,183 prescribers (2%). Above this entry. 1,600–1,800: 19,917 prescribers (1%). Above this entry. 1,800–2,000: 17,585 prescribers (1%). Above this entry. 2K+: 226,899 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.

Source CMS Medicare Part D Prescriber Public Use File · 2024

Board certification likely (heuristic, not verified)

Peter Knapp, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Peter Knapp, M.D.?

CMS neutral score, not measured

NPI registry status

Active

Issued 07/28/2006

NPI 1013921709

Primary specialty

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician

Niche

621 US NPIs in this specialty

Medicare Part D claims

1,045 58% vs specialty avg

2024 prescription claims

Specialty avg: 661

MIPS final score

75/100

CMS neutral score, not measured

No category scores published; CMS assigned the performance threshold

Specialty distribution in Indiana

How Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician compares to other specialties among Indiana providers

Indiana providers
Behavior Technician14.3%Student in an Organized Heal…4.8%Pharmacist4.3%Clinical Social Worker4.2%Family Nurse Practitioner4.2%Mental Health Counselor4.1%Urogynecology and Reconstruc…0%
Largest specialties in Indiana (% of in-state providers)

MIPS score not measured

CMS assigned a neutral 75/100 threshold

CMS did not publish any Quality, Cost, Promoting Interoperability, or Improvement Activities category score for this clinician. This administrative threshold is not comparable with the national average of clinicians whose MIPS score was measured.

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

12188A N MERIDIAN ST
Carmel, IN 46032

Provider Details

NPI 1013921709
Specialty Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
Credentials M.D.
Gender Male
NPI Issued 07/28/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
CMS neutral threshold · not measured

Reporting: Group practice

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Peter Knapp, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$147

Largest payer

Janssen Biotech, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

Peter Knapp, M.D. - brand share 14.0%
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician average

14% brand-name claims vs 86% generic, on 1,045 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

1,045
Total Claims
$169K
Total Drug Cost
317
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,703.167
Total Day Supply
80,186
Brand vs Generic
14% brand / 86% generic
Brand Drug Cost
$129K
Generic Drug Cost
$39K
Antibiotic Claims
111

Patient Demographics

Average Patient Age
76.3 years
Avg HCC Risk Score
1.51
Gender Split
18% female / 82% male
Age Distribution
<65: 19, 65-74: 112, 75-84: 134, 85+: 52

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Peter Knapp, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Tamsulosin Hcl
359
Oxybutynin Chloride Er
Oxybutynin Chloride
99
Duloxetine Hcl
79
Trospium Chloride
65
Myrbetriq
Mirabegron
64
Gemtesa
Vibegron
40
Finasteride
37
Cephalexin
28
Sulfamethoxazole-Trimethoprim
Sulfamethoxazole/Trimethoprim
24
Oxybutynin Chloride
23

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Overview

How Peter Knapp, M.D. fits within the Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician landscape nationally.

621
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in US
50
States with Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
661
Avg Claims per Provider

Peter Knapp, M.D.'s 1,045 claims are above the specialty average of 661.

Nationwide Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Knapp, both outside Indiana so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (75 here).

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician Providers in Indiana

Other clinicians with the same primary specialty enrolled in Indiana, drawn from the same CMS NPPES roster as Knapp.

One of 14 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers enrolled in Indiana, 5 are shown here.

Compare Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Peter Knapp, M.D.'s specialty?
Peter Knapp, M.D. specializes in Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician and practices in Carmel, Indiana. Credentials: M.D..
How much does Peter Knapp, M.D. prescribe under Medicare Part D?
In 2024, Peter Knapp, M.D. wrote 1,045 Medicare Part D claims totaling $169K in drug costs for 317 beneficiaries.
What is Peter Knapp, M.D.'s Medicare quality score?
Peter Knapp, M.D. has a CMS MIPS Final Score of 75/100. CMS published no Quality, Promoting Interoperability, Improvement Activity or Cost score for this clinician, so the final score is the neutral performance threshold CMS assigns rather than a measured result. The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Peter Knapp, M.D. located?
Peter Knapp, M.D. is located at 12188A N MERIDIAN ST, Carmel, IN, 46032. Phone: (317) 564-5100.
What is Peter Knapp, M.D.'s NPI number?
Peter Knapp, M.D.'s National Provider Identifier (NPI) is 1013921709, issued on 07/28/2006.
Does Peter Knapp, M.D. prescribe more brand-name or generic drugs?
Peter Knapp, M.D.'s prescribing is 14% brand-name and 86% generic drugs by claim count, with $129K in brand drug costs.
How many Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers are there in the US?
There are 621 Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician providers across 50 states in the US. The average Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician provider writes 661 Medicare Part D claims per year.
What drugs does Peter Knapp, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Peter Knapp, M.D.'s most frequently prescribed drugs include Tamsulosin Hcl, Oxybutynin Chloride Er, Duloxetine Hcl. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Peter Knapp, M.D. accept Medicare?
Peter Knapp, M.D. appears in CMS Medicare data with 1,045 Part D claims and 317 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Peter Knapp, M.D.'s credentials?
Peter Knapp, M.D.'s NPI is 1013921709 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.